Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man

Regulatory Peptides

Volumn 158, Issue 1-3, 2009, Pages 57-62

  Witte, A B ^a   Gryback P ^a   Holst, J J ^b   Hilsted, L ^c   Hellstrom P M ^a   Jacobsson, H ^a   Schmidt, P T ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Gastric emptying; Metabolic control; Nausea; Peptide YY; Satiety

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PEPTIDE YY; PEPTIDE YY [3-36]; PEPTIDE YY[1-36]; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; APPETITE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INHIBITION KINETICS; INSULIN BLOOD LEVEL; MALE; METABOLIC REGULATION; NAUSEA; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY; SINGLE BLIND PROCEDURE; STOMACH EMPTYING;

ADULT; APPETITE; BLOOD GLUCOSE; FEMALE; GASTRIC EMPTYING; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; MALE; NAUSEA; PEPTIDE YY; SINGLE-BLIND METHOD;

EID: 70349742222     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.07.013     Document Type: Article

References (50)

1. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., and Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89 5 (1985) 1070-1077
2. Greeley Jr. G.H., Hill F.L., Spannagel A., and Thompson J.C. Distribution of peptide YY in the gastrointestinal tract of the rat, dog, and monkey. Regul Pept 19 5-6 (1987) 365-372
3. Kishimoto S., Kato R., Mukai T., et al. Distribution and endocrine morphology of polypeptide YY (PYY) containing cells in the human gut. Hiroshima J Med Sci 34 1 (1985) 155-160
4. Lundberg J.M., Tatemoto K., Terenius L., et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A 79 14 (1982) 4471-4475
5. Roddy D.R., Koch T.R., Reilly W.M., Carney J.A., and Go V.L. Identification and distribution of immunoreactive peptide YY in the human, canine, and murine gastrointestinal tracts: species-related antibody recognition differences. Regul Pept 18 3-4 (1987) 201-212
6. Armstrong D.N., Krenz H.K., Modlin I.M., and Ballantyne G.H. Bile salt inhibition of motility in the isolated perfused rabbit terminal ileum. Gut 34 4 (1993) 483-488
7. Cuche G., Cuber J.C., and Malbert C.H. Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway. Am J Physiol Gastrointest Liver Physiol 279 5 (2000) G925-G930
8. Dumoulin V., Moro F., Barcelo A., Dakka T., and Cuber J.C. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology 139 9 (1998) 3780-3786
9. Hoentjen F., Hopman W.P., and Jansen J.B. Effect of circulating peptide YY on gallbladder emptying in humans. Scand J Gastroenterol 36 10 (2001) 1086-1091
10. Lin H.C., Zhao X.T., Wang L., and Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 110 5 (1996) 1491-1495
11. Nightingale J.M., Kamm M.A., van Jr. d.S., Ghatei M.A., Bloom S.R., and Lennard-Jones J.E. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut 39 2 (1996) 267-272
12. Pironi L., Stanghellini V., Miglioli M., et al. Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105 3 (1993) 733-739
13. Savage A.P., Adrian T.E., Carolan G., Chatterjee V.K., and Bloom S.R. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28 2 (1987) 166-170
14. Spiller R.C., Trotman I.F., Higgins B.E., et al. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man. Gut 25 4 (1984) 365-374
15. Eberlein G.A., Eysselein V.E., Schaeffer M., et al. A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides 10 4 (1989) 797-803
16. Grandt D., Schimiczek M., Beglinger C., et al. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51 2 (1994) 151-159
17. Grandt D., Schimiczek M., Struk K., et al. Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36), in the rabbit. Peptides 15 5 (1994) 815-820
18. Eissele R., Goke R., Willemer S., et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Investig 22 4 (1992) 283-291
19. Ballantyne G.H. Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions. Obes Surg 16 5 (2006) 651-658
20. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 131 2 (2006) 640-658
21. Batterham R.L., Cowley M.A., Small C.J., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 6898 (2002) 650-654
22. Degen L., Oesch S., Casanova M., et al. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 129 5 (2005) 1430-1436
23. Le Roux C.W., Batterham R.L., Aylwin S.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147 1 (2006) 3-8
24. Sloth B., Davidsen L., Holst J.J., Flint A., and Astrup A. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am J Physiol Endocrinol Metabol Gastrointest Physiol 293 2 (2007) E604-E609
25. Sloth B., Holst J.J., Flint A., Gregersen N.T., and Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metabol Gastrointest Physiol 292 4 (2007) E1062-E1068
26. Allen J.M., Fitzpatrick M.L., Yeats J.C., Darcy K., Adrian T.E., and Bloom S.R. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 30 4 (1984) 255-262
27. Chelikani P.K., Haver A.C., and Reidelberger R.D. Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 287 5 (2004) R1064-R1070
28. Moran T.H., Smedh U., Kinzig K.P., Scott K.A., Knipp S., and Ladenheim E.E. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 288 2 (2005) R384-R388
29. Gryback P., Hermansson G., Lyrenas E., Beckman K.W., Jacobsson H., and Hellstrom P.M. Nationwide standardisation and evaluation of scintigraphic gastric emptying: reference values and comparisons between subgroups in a multicentre trial. Eur J Nucl Med 27 6 (2000) 647-655
30. Albano J.D., Ekins R.P., Maritz G., and Turner R.C. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) 70 3 (1972) 487-509
31. Schmidt P.T., Ljung T., Hartmann B., Hare K.J., Holst J.J., and Hellstrom P.M. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY. Eur J Gastroenterol Hepatol 17 2 (2005) 207-212
32. Chelikani P.K., Haver A.C., and Reidelberger R.D. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146 2 (2005) 879-888
33. Wynne K., Stanley S., and Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 89 6 (2004) 2576-2582
34. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., and Reeve Jr. J.R. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol 279 1 (2000) G126-G131
35. Chen C.H., Stephens Jr. R.L., and Rogers R.C. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol Motil 9 2 (1997) 109-116
36. Degen L., Drewe J., Piccoli F., et al. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. Am J Physiol Regul Integr Comp Physiol 292 4 (2007) R1391-R1399
37. Adrian T.E., Long R.G., Fuessl H.S., and Bloom S.R. Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci 30 12 (1985) 1145-1148
38. Morinigo R., Moize V., Musri M., et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 91 5 (2006) 1735-1740
39. Weickert M.O., Spranger J., Holst J.J., Otto B., Koebnick C., Möhlig M., and Pfeiffer A.F. Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety. Br J Nutr 96 5 (2006) 795-798
40. Juvonen K.R., Purhonen A.K., Salmenkallio-Marttila M., Lähteenmäki L., Laaksonen D.E., Herzig K.H., Uusitupa M.I., Poutanen K.S., and Karhunen L.J. Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans. J Nutr 139 3 (2009) 461-466
41. Greeley Jr. G.H., Lluis F., Gomez G., Ishizuka J., Holland B., and Thompson J.C. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs. Am J Physiol 254 4 Pt 1 (1988) E513-E517
42. Pappas T.N., Debas H.T., Goto Y., and Taylor I.L. Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 248 1 Pt 1 (1985) G118-G123
43. Bottcher G., Ahren B., Lundquist I., and Sundler F. Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse. Pancreas 4 3 (1989) 282-288
44. Aponte G.W., Fink A.S., Meyer J.H., Tatemoto K., and Taylor I.L. Regional distribution and release of peptide YY with fatty acids of different chain length. Am J Physiol 249 6 Pt 1 (1985) G745-G750
45. Szecowka J., Tatemoto K., Rajamaki G., and Efendic S. Effects of PYY and PP on endocrine pancreas. Acta Physiol Scand 119 2 (1983) 123-126
46. Boey D., Sainsbury A., and Herzog H. The role of peptide YY in regulating glucose homeostasis. Peptides 28 2 (2007) 390-395
47. Adrian T.E., Sagor G.R., Savage A.P., Bacarese-Hamilton A.J., Hall G.M., and Bloom S.R. Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man. J Clin Endocrinol Metab 63 4 (1986) 803-807
48. Ahren B., and Larsson H. Peptide YY does not inhibit glucose-stimulated insulin secretion in humans. Eur J Endocrinol 134 3 (1996) 362-365
49. Batterham R.L., Cohen M.A., Ellis S.M., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 10 (2003) 941-948
50. Neary N.M., Small C.J., Druce M.R., et al. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 146 12 (2005) 5120-5127